Datacolor Announces Launch of Next Generation of Precision Portable Spectrophotometers, Spectro P Series
LAWRENCEVILLE, N.J., March 12, 2025 /PRNewswire/ -- Datacolor, a global leader in…
Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis
Significantly more patients treated with Sotyktu achieved ACR and PASI response rates…
HTX’s USDD Earn Now Offers 20% APY: Hedge Against Crypto Crash with High Yield
SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- As the cryptocurrency market faces renewed turbulence, Bitcoin…
GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
GCCL is committed to customer success, emphasizing quality control at every stage—from…
CryptMains Symbiotic Union with Nuclear Energy Powering the Future of Crypto Mining and Cloud Computing
Oslo, Norwa, Jan. 31, 2025 (GLOBE NEWSWIRE) -- CryptMain is reshaping the future…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle
Daily Fit Notes, founded by Justin Brey in New York, launches a…
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity,…
Viking Engineering Laboratory Achieves ISO 17025 Accreditation
HOUSTON, Dec. 11, 2024 /PRNewswire/ -- Viking Engineering, a 100% employee-owned GATE…
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
A 30% reduction in long episodes was shown to be associated with…